drugset / Trial / NCT00748787
Trial to Evaluate the Effect of Plantago Ovata Husk in the Remission of Metabolic Syndrome in Children and Adolescents
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The metabolic syndrome represents a constellation of risk factors associated to the abdominal obesity that includes insulin resistance, lipids alterations, high blood pressure etc. Several studies support the hypothesis that the intake of soluble fiber might have a positive effect in the improvement of such of these risk factors. So that, the aim of this study is to evaluate the efficacy of Ispaghula husk in the remission of metabolic syndrome in children between 10 to 16 years old.
Timeline
- Start
- 2008-10
- Primary completion
- 2009-11
- Completion
- 2010-06
Outcome
Outcome not reported
Stopped: “It was very difficult to fulfill the inclusion criteria, therefore the expected time of inclusion was delayed so much time.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ispaghula husk | Unknown | 3.5 g | Oral |